Inventor · disambiguated record
Nina Liu
Also filed as: LIU NINA
10 granted patents·4 pending applications·8 citations·filing 2017–2025
84Inventor score
Top patents by PatentIndex Score
14 records- 0196US12180272B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Dec 31, 2024·2 cites·11 claims
- 0296US11708407B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Jul 25, 2023·2 cites·26 claims
- 0392US12391753B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 0491US12215148B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2020·Granted Feb 4, 2025·2 cites·25 claims
- 0591US2025333492A1Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0690US12331109B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Jun 17, 2025·0 cites·23 claims
- 0787US11965020B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2023·Granted Apr 23, 2024·0 cites·24 claims
- 0887US2025289883A1Novel antigen binding molecule formatsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0986US11754569B2Methods for characterizing protein complexesREGENERON PHARMA·Filed 2019·Granted Sep 12, 2023·2 cites·20 claims
- 1078US12474349B2Methods for characterizing protein complexesREGENERON PHARMA·Filed 2023·Granted Nov 18, 2025·0 cites·18 claims
- 1178US2024167984A1Methods for detecting and determining protein structures and stability in fluids, including biological fluidsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1278US2024168018A1Methods for detecting and evaluating viruses and virus-like particlesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1368US11905322B2Engineered PD-1 variantsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 1458US11352413B2Engineered PD-1 variantsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted Jun 7, 2022·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Nina Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →